HPVC2026-058: Pharmaceutical Products

Update: 10^th April 2026

HSV has made an update to the Pharmaceutical Products (HPVITS2026-058). Please find the updated information below:

Upcoming Procurement Activity

Upcoming Supplementary Tender #001

Market Release Date: 15 April 2026

Market Closing Date: 6 May 2026

Title: HPVITS2026-058.001 Pharmaceutical Products - Supplementary 001

Scope for Supplementary 001:

488.01 - Isavuconazole 100 mg Capsule

228.04 - Iron (as Ferric Carboxymaltose) 100 mg/2 mL Injection, 2 mL Ampoule/Vial

228.05 - Iron (as Ferric Carboxymaltose) 500 mg/10 mL Injection, 10 mL Ampoule/Vial

228.06 - Iron (as Ferric Carboxymaltose) 1000 mg/20 mL Injection, 20 mL Ampoule/Vial

6021.01 - Tocilizumab 162 mg Injection, Syringe

6021.02 - Tocilizumab 162 mg Injection, Pen Device

6021.03 - Tocilizumab 80 mg Injection, Ampoule/Vial

6021.04 - Tocilizumab 200 mg Injection, Ampoule/Vial

6021.05 - Tocilizumab 400 mg Injection, Ampoule/Vial

All enquiries regarding this supplementary tender prior to the market release date should be directed to sheerin.kaur@healthsharevic.org.au.

Once the tender has been released, please direct all correspondence through the HSV Procurement Portal.

Important Note:

Please ensure you are registered to access the Procurement Portal and your details are up to date. More information can be found on the HSV website, or contact:

HSV Helpdesk

Phone: (03) 9947 3900

Email:helpdesk@healthsharevic.org.au

Tentative Dates

Announcement of outcome to suppliers: 19 June 2026

Announcement of outcome to health services: 7 July 2026

Contract Commencement Date: 13 July 2026